The impact of weight loss on risk for endometrial cancer in postmenopausal women was assessed in women enrolled in the Women's Health Initiative observational study.
Adjuvant chemotherapy administered during and after radiotherapy is feasible for the treatment of patients with high-risk endometrial cancer despite an increased risk of toxicities compared with radiotherapy alone.
Nurse-based telephone follow-up was as effective as traditional hospital based follow-up for for stage I endometrial cancer.
Minimally invasive hysterectomy does not appear to compromise long-term survival compared with abdominal hysterectomy.
Adding continuous progestin to estrogen lowers the risk of endometrial cancer in postmenopausal women, according to a new study.
Bariatric surgery slashed the weight of obese women who are most at risk for cancer by one-third, produced a mean weight loss of more than 100 pounds, and eliminated precancerous uterine growths. It also improved physical quality of life, improved insulin levels and glucose use, and altered the composition of gut bacteria.
Non-Hispanic black women with endometrial cancer display worse outcomes when compared to women in other racial/ethnic groups diagnosed with the same subtype of endometrial cancer.
Non-Hispanic black women have higher endometrial cancer incidence and lower survival across all stages and subtypes.
Oral contraceptives protect against endometrial cancer, and the protective benefit lasts for many years after women stop taking the pills.
Use of oral contraceptives, even short-term, offers significant long-term protection against endometrial cancer and the protective effect seems to linger for decades after contraceptive is discontinued.
Women with cervical or endometrial cancer can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal toxicity.
Researchers have found an association between the risk of endometrial cancer and the age of first menstrual cycle, having given birth, and hormonal contraceptive use for women with Lynch syndrome.
Qualifications to guidelines include stronger statements in favor of chemotherapy in some cases.
Use of robotic surgery showed no differences in blood loss, complication rates, or survival between morbidly obese and lower-weight patients.
Nut consumption is associated with a reduced risk for developing certain types of cancer, but not type 2 diabetes.
Women who followed a Mediterranean-style diet saw a significant reduction in their risk of endometrial cancer, according to a new study.
Women who eat a Mediterranean diet reduce their risk of womb cancer (endometrial cancer) by more than half.
Brachytherapy, with or without external beam radiation, can improve survival in women with inoperable, early stage endometrial cancer.
A reduction in endometrial cancer risk with oral bisphosphonate use in large cohort of postmenopausal women has been observed.
Soy food/isoflavone consumption is not associated with endometrial cancer risk in Japanese women.
Drinking three to four cups of coffee per day may reduce a woman's risk of developing endometrial cancer by nearly a fifth.
A metabolic syndrome diagnosis is linked with higher risk of endometrial cancer; excess weight likely a big factor, but other conditions also appear to play a part.
Whether the association with endometrial cancer was due to obesity or metabolic syndrome was unclear.
Hispanic women in the United States were significantly less likely to survive endometrial uterine cancer than non-Hispanic white women.
Nitrogen-containing bisphosphonates have been associated with reduced risk of endometrial cancer, according to research.
Radiation therapy with concurrent paclitaxel chemotherapy after surgery can be effective to treat patients with high-risk endometrial cancer, according to new research.
A new study of Japanese women showed no evidence for a protective association between soy food or isoflavone intake and risk of endometrial cancer.
There is no association between soy consumption and endometrial cancer risk, according to a study published online in BJOG: An International Journal of Obstetrics & Gynaecology.
The use of adjuvant radiation therapy in the treatment of endometrial cancer is detailed in a new guideline issued by the American Society of Radiation Oncology (ASTRO).
Scientific evidence is mounting that warrants screening all patients with endometrial cancer for Lynch syndrome.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|